Central retinal vein occlusion

Known as: Central Retinal Venous Occlusion, central occlusions retinal vein, central retinal thrombosis vein 
Blockage of the central retinal vein.
National Institutes of Health

Related topics

Related topics

6 relations
Cardiovascular systemEyeRetinaRetinal Diseases
(More)

Broader (1)

Retinal Vein Occlusion

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.
PURPOSE To assess the efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg ranibizumab in patients with macular… (More)
Is this relevant?
2007
2007
Central retinal vein occlusion case-control study.
PURPOSE To investigate risk factors for central retinal vein occlusion (CRVO). DESIGN Retrospective case-control study… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
PURPOSE To report the short term anatomic and visual acuity response after intravitreal injection of bevacizumab (Avastin… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.
To determine whether bevacizumab could improve visual acuity and optical coherence tomography outcomes in a patient with macular… (More)
Is this relevant?
Review
2003
Review
2003
Management of central retinal vein occlusion.
The management of central retinal vein occlusion (CRVO) is discussed briefly. Since the prognosis, complications, visual outcome… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases.
PURPOSE Retinal vascular occlusive disease is the second leading cause of permanent retinal blindness. The etiology of central… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Vascular endothelial growth factor upregulation in human central retinal vein occlusion.
BACKGROUND AND OBJECTIVE Vascular endothelial growth factor (VEGF), a key mediator of intraocular neovascularization, is… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
  • Archives of ophthalmology
  • 1997
OBJECTIVE To provide clinical management guidelines for eyes with central retinal vein occlusion. DESIGN Prospective cohort… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase
We investigated prospectively in 128 patients (140 eyes) the role of six routine clinical tests in the differentiation of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Classification of central retinal vein occlusion.
Our prospective clinical study of 360 eyes with central retinal vein occlusion (CRVO) and our experimental studies on CRVO in 54… (More)
Is this relevant?